#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15148	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2370	777.3	0	.	n	.	0	T536C	SNP	536	536	T	984	984	C	917	C,T,G,A	660,255,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15148	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2370	777.3	0	.	n	.	0	T1157C	SNP	1157	1157	T	1605	1605	C	931	C,T,G	927,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15148	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2370	777.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1898	1898	T	1014	T,A,G	1011,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15148	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2370	777.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1632	1632	C	929	C,T	928,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15148	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2370	777.3	0	HET	.	.	.	C321T,G	.	321	321	C	769	769	C	890	C,T,G	645,243,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15148	16S	1529	1529	99.8	16S.l6.c17.ctg.1	2370	777.3	0	HET	.	.	.	A337G,C,T	.	337	337	A	785	785	A	917	A,G,C,T	666,248,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25960	23S	2890	2890	99.93	23S.l6.c30.ctg.1	4106	789.0	0	.	n	.	0	C1623T	SNP	1623	1623	C	2263	2263	T	922	T,A,C	919,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25960	23S	2890	2890	99.93	23S.l6.c30.ctg.1	4106	789.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2611	2611	C	895	C,T	894,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25960	23S	2890	2890	99.93	23S.l6.c30.ctg.1	4106	789.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2685	2685	A	811	A,C	810,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25960	23S	2890	2890	99.93	23S.l6.c30.ctg.1	4106	789.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3237	3237	C	900	C,G	898,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25960	23S	2890	2890	99.93	23S.l6.c30.ctg.1	4106	789.0	0	HET	.	.	.	C2626CGGGGG,CGGGG	.	2626	2626	C	3266	3266	C	943	CGGGGG,CGGGG	756,141	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	G5V	NONSYN	13	15	GGT	620	622	GTT	117;118;117	G,T;T;T	116,1;118;117	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	E12K	NONSYN	34	36	GAA	641	643	AAA	129;130;131	A;A;A	129;130;131	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	F31L	NONSYN	91	93	TTT	698	700	TTG	181;182;184	T;T;G	181;182;184	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	731	733	CAA	208;209;208	C;A;A	208;209;208	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	S75P	NONSYN	223	225	TCC	830	832	CCT	165;164;165	C,A;C;T,C	164,1;164;164,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	V87A	NONSYN	259	261	GTA	866	868	GCG	164;166;168	G;C,G;G	164;165,1;168	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	V89A	NONSYN	265	267	GTC	872	874	GCG	169;168;168	G;C;G	169;168;168	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	V130L	NONSYN	388	390	GTC	995	997	CTC	199;198;199	C,G;T;C,A	198,1;198;198,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	R135C	NONSYN	403	405	CGC	1010	1012	TGT	208;205;204	T;G;T	208;205;204	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	T137A	NONSYN	409	411	ACG	1016	1018	GCG	212;211;212	G,T;C;G	211,1;211;212	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1058	1060	AAG	233;232;228	A;A;G,C	233;232;227,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1061	1063	AAT	231;234;233	A;A;T	231;234;233	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1259	1261	TTG	142;141;141	T,G;T,G;G,A	141,1;140,1;140,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1289	1291	AGC	122;123;124	A,G;G;C	121,1;123;124	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1358	1360	CTG	119;117;118	C;T;G	119;117;118	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1364	1366	TCC	121;121;121	T;C;C	121;121;121	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1379	1381	GTG	136;136;134	G;T;G	136;136;134	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.54	folP.l6.c4.ctg.1	2042	102.2	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1430	1432	GCG	162;162;163	G,T;C;G	161,1;162;163	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4744	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4123	143.6	1	SNP	p	S91F	1	.	.	271	273	TTC	1002	1004	TTC	168;167;165	T,G,A;T,G;C	166,1,1;166,1;165	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4744	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4123	143.6	1	SNP	p	G95N	0	.	.	283	285	GGC	1014	1016	GGC	165;165;166	G;G;C	165;165;166	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4744	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4123	143.6	1	SNP	p	D95G	1	.	.	283	285	GGC	1014	1016	GGC	165;165;166	G;G;C	165;165;166	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1992	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1963	126.5	1	SNP	p	G45D	1	.	.	133	135	GAC	837	839	GAC	228;231;232	G;A,T,G,C;C	228;228,1,1,1;232	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1146	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1727	82.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3533	168.1	1	SNP	p	D86N	0	.	.	256	258	GAC	852	854	GAC	201;201;197	G;A,G,C;C	201;199,1,1;197	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3533	168.1	1	SNP	p	S87W	0	.	.	259	261	AGT	855	857	AGT	195;196;195	A,C;G;T,G	194,1;196;193,2	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3533	168.1	1	SNP	p	S87I	0	.	.	259	261	AGT	855	857	AGT	195;196;195	A,C;G;T,G	194,1;196;193,2	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3533	168.1	1	SNP	p	S87R	0	.	.	259	261	AGT	855	857	AGT	195;196;195	A,C;G;T,G	194,1;196;193,2	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3533	168.1	1	SNP	p	S88P	0	.	.	262	264	TCC	858	860	TCC	197;197;200	T;C,T,G;C,T,G	197;195,1,1;197,1,2	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4066	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3206	158.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1780	1782	GGC	203;199;205	G;G;C	203;199;205	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1551	1553	GCA	222;221;220	G;C;A	222;221;220	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1554	1556	ATC	217;220;220	A;T;C,G	217;220;219,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1566	1568	GTG	222;222;222	G;T,A;G	222;221,1;222	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1566	1568	GTG	222;222;222	G;T,A;G	222;221,1;222	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2070	2072	ACC	227;228;230	A;C;C	227;228;230	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2124	2126	GCG	222;220;222	G;C;G	221;220;222	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2124	2126	GCG	222;220;222	G;C;G	221;220;222	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2247	2249	GGT	206;205;205	G,T;G;T	205,1;205;205	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2256	2258	GGC	216;215;216	G;G;C,T,A	216;215;214,1,1	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	166.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2274	2276	CCG	233;233;230	C;C,A;G	233;232,1;230	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5648	ponA	2397	2397	99.83	ponA.l6.c4.ctg.1	3525	199.4	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1798	1800	ACG	207;205;204	A;C;G	207;205;204	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5648	ponA	2397	2397	99.83	ponA.l6.c4.ctg.1	3525	199.4	0	.	p	.	0	A471T	NONSYN	1411	1413	GCA	2086	2088	ACA	270;270;270	A,G,C;C;A,G,T	268,1,1;270;268,1,1	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5648	ponA	2397	2397	99.83	ponA.l6.c4.ctg.1	3525	199.4	0	.	p	.	0	T692M	NONSYN	2074	2076	ACG	2749	2751	ATG	207;207;207	A,C;T,G;G	206,1;206,1;207	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5648	ponA	2397	2397	99.83	ponA.l6.c4.ctg.1	3525	199.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1936	1938	CTG	257;257;256	C,T;T;G	256,1;257;256	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2442	porA	1146	1146	99.65	porA.l15.c17.ctg.1	2468	123.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	978	978	C	181	C	181	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	13	15	TTA	32;36;40	T;T;A	32;36;40	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	58	60	CAT	66;66;66	C;A;T	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	61	63	AGT	66;66;66	A;G;T	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	70	72	TAC	66;66;66	T;A;C	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	R307E	NONSYN	919	921	AGA	160	162	GAA	3;3;3	G;A;A	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	172	174	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	181	183	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	187	189	TCG	4;4;4	T;C;G	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	193	195	GCC	4;4;5	G;C;C	4;4;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	196	198	AGC	5;5;5	A;G;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	199	201	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	312	porB1a	984	222	90.99	porB1a.l15.c17.ctg.2	329	30.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	205	207	GTT	6;6;6	G;T;T	6;6;6	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3200	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	2285	174.7	0	.	p	.	0	.	INDELS	629	630	AA	1251	1253	TAG	284;284;282	T;A;G	284;284;282	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3200	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	2285	174.7	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1255	1258	CAAT	281;283;287;286	C,A;A;A,T;T	280,1;283;286,1;286	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3200	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	2285	174.7	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1260	1260	T	287	T	287	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3200	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	2285	174.7	1	SNP	p	G120K	0	.	.	358	360	GGT	979	981	GGT	238;238;239	G;G;T,G	238;238;238,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3200	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	2285	174.7	1	SNP	p	A121D	0	.	.	361	363	GCC	982	984	GCC	246;247;246	G;C;C,G	246;247;244,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3200	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	2285	174.7	1	SNP	p	A121N	0	.	.	361	363	GCC	982	984	GCC	246;247;246	G;C;C,G	246;247;244,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11110	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5467	253.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2273	2275	CAT	274;273;271	C,T,G;A;T	272,1,1;273;271	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1680	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1746	120.2	1	SNP	p	V57M	1	.	.	169	171	ATG	900	902	ATG	262;261;261	A;T;G,T	262;261;260,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	10694	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	3091	431.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
